ScholarIQanswers from OpenAlex
ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer
PaperCitations, authors & open-access status
ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer have?
ScholarIQcitation count
ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer has 26 citations in the OpenAlex counts ScholarIQ stores.
When was ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer published?
ScholarIQyear
ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer has 2021 year in the ScholarIQ index.
What is the open-access status of ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer?
ScholarIQoa status
ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer has bronze oa status in the ScholarIQ index.
What is the DOI of ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer?
ScholarIQdoi
The DOI for ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer is on the source record.
What is the PMID of ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer?
ScholarIQpmid
The PMID for ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer is on the source record.
What is the OpenAlex record for ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer?
ScholarIQopenalex
The OpenAlex for ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer is on the source record.